Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TER-101 in mild to moderate atopic dermatitis
NCT04753034Phase 2Completed
- Sponsor
- Teres Bio, Inc.
- Start
- Jan 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ter-101 in atopic dermatitis (AD), sponsored by Teres Bio, Inc.. Started Jan 2021; status: completed.
02
Drugs
ter-101
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04753034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04753034.